A multifunctional envelope-type nanodevice for use in nanomedicine: Concept and applications

Accounts of Chemical Research

Volumn 45, Issue 7, 2012, Pages 1113-1121

  Nakamura, T ^a   Akita, H ^a   Yamada, Y ^a   Hatakeyama, H ^a   Harashima, H ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NANOMATERIAL; NUCLEIC ACID; OCTAARGININE; OLIGOPEPTIDE; PROTEIN;

ARTICLE; CELL NUCLEUS; CHEMISTRY; CYTOSOL; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; METABOLISM; MITOCHONDRION; NANOMEDICINE; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL NUCLEUS; CYTOSOL; HELA CELLS; HUMANS; MITOCHONDRIA; NANOMEDICINE; NANOSTRUCTURES; NUCLEIC ACIDS; OLIGOPEPTIDES; PROTEINS; TRANSFECTION;

EID: 84862902284     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/ar200254s     Document Type: Article

References (40)

1. Kogure, K.; Akita, H.; Yamada, Y.; Harashima, H. Multifunctional envelope-type nanodevice (MEND) as a non-viral gene delivery system Adv. Drug Delivery Rev. 2008, 60, 559-571
2. Hatakeyama, H.; Akita, H.; Harashima, H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: A strategy for overcoming the PEG dilemma Adv. Drug Delivery Rev. 2011, 63, 152-160
3. Futaki, S.; Ohashi, W.; Suzuki, T.; Niwa, M.; Tanaka, S.; Ueda, K.; Harashima, H.; Sugiura, Y. Stearylated arginine-rich peptides: A new class of transfection systems Bioconjugate Chem. 2001, 12, 1005-1011
4. Khalil, I. A.; Kogure, K.; Futaki, S.; Harashima, H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression J. Biol. Chem. 2006, 281, 3544-3551
5. Khalil, I. A.; Kogure, K.; Akita, H.; Harashima, H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery Pharmacol. Rev. 2006, 58, 32-45
6. El-Sayed, A.; Khalil, I. A.; Kogure, K.; Futaki, S.; Harashima, H. Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape J. Biol. Chem. 2008, 283, 23450-23461
7. Nakamura, T.; Moriguchi, R.; Kogure, K.; Shastri, N.; Harashima, H. Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes Mol. Ther. 2008, 16, 1507-1514
8. Homhuan, A.; Kogure, K.; Akaza, H.; Futaki, S.; Naka, T.; Fujita, Y.; Yano, I.; Harashima, H. New packaging method of mycobacterial cell wall using octaarginine-modified liposomes: Enhanced uptake by and immunostimulatory activity of dendritic cells J. Controlled Release 2007, 120, 60-69
9. Joraku, A.; Homhuan, A.; Kawai, K.; Yamamoto, T.; Miyazaki, J.; Kogure, K.; Yano, I.; Harashima, H.; Akaza, H. Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guerin BJU Int. 2009, 103, 686-693
10. Kogure, K.; Moriguchi, R.; Sasaki, K.; Ueno, M.; Futaki, S.; Harashima, H. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method J. Controlled Release 2004, 98, 317-323
11. Khalil, I. A.; Kogure, K.; Futaki, S.; Hama, S.; Akita, H.; Ueno, M.; Kishida, H.; Kudoh, M.; Mishina, Y.; Kataoka, K.; Yamada, M.; Harashima, H. Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery Gene Ther. 2007, 14, 682-689
12. Nakamura, Y.; Kogure, K.; Futaki, S.; Harashima, H. Octaarginine-modified multifunctional envelope-type nano device for siRNA J. Controlled Release 2007, 119, 360-367
13. Leopold, P. L.; Kreitzer, G.; Miyazawa, N.; Rempel, S.; Pfister, K. K.; Rodriguez-Boulan, E.; Crystal, R. G. Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis Hum. Gene Ther. 2000, 11, 151-165
14. Subramanian, A.; Ranganathan, P.; Diamond, S. L. Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells Nat. Biotechnol. 1999, 17, 873-877
15. Akita, H.; Enoto, K.; Masuda, T.; Mizuguchi, H.; Tani, T.; Harashima, H. Particle tracking of intracellular trafficking of octaarginine-modified liposomes: a comparative study with adenovirus Mol. Ther. 2010, 18, 955-964
16. Akita, H.; Kudo, A.; Minoura, A.; Yamaguti, M.; Khalil, I. A.; Moriguchi, R.; Masuda, T.; Danev, R.; Nagayama, K.; Kogure, K.; Harashima, H. Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process Biomaterials 2009, 30, 2940-2949
17. Shaheen, S. M.; Akita, H.; Nakamura, T.; Takayama, S.; Futaki, S.; Yamashita, A.; Katoono, R.; Yui, N.; Harashima, H. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine. Biomaterials 2012, in press.
18. Hama, S.; Akita, H.; Iida, S.; Mizuguchi, H.; Harashima, H. Quantitative and mechanism-based investigation of post-nuclear delivery events between adenovirus and lipoplex Nucleic Acids Res. 2007, 35, 1533-1543
19. Hama, S.; Akita, H.; Ito, R.; Mizuguchi, H.; Hayakawa, T.; Harashima, H. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems Mol. Ther. 2006, 13, 786-794
20. Shaheen, S. M.; Akita, H.; Yamashita, A.; Katoono, R.; Yui, N.; Biju, V.; Ishikawa, M.; Harashima, H. Quantitative analysis of condensation/ decondensation status of pDNA in the nuclear sub-domains by QD-FRET Nucleic Acids Res. 2011, 39, e48
21. Yamashita, A.; Kanda, D.; Katoono, R.; Yui, N.; Ooya, T.; Maruyama, A.; Akita, H.; Kogure, K.; Harashima, H. Supramolecular control of polyplex dissociation and cell transfection: efficacy of amino groups and threading cyclodextrins in biocleavable polyrotaxanes J. Controlled Release 2008, 131, 137-144
22. Holt, I. J.; Harding, A. E.; Morgan-Hughes, J. A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies Nature 1988, 331, 717-719
23. Tuppen, H. A.; Blakely, E. L.; Turnbull, D. M.; Taylor, R. W.; Mitochondrial, D. N. A. mutations and human disease Biochim. Biophys. Acta 2010, 1797, 113-128
24. Zhang, E.; Zhang, C.; Su, Y.; Cheng, T.; Shi, C. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy Drug Discovery Today 2011, 16, 140-146
25. Flierl, A.; Jackson, C.; Cottrell, B.; Murdock, D.; Seibel, P.; Wallace, D. C. Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid Mol. Ther. 2003, 7, 550-557
26. DSouza, G. G.; Boddapati, S. V.; Weissig, V. Mitochondrial leader sequence-plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria Mitochondrion 2005, 5, 352-358
27. Yamada, Y.; Akita, H.; Kamiya, H.; Kogure, K.; Yamamoto, T.; Shinohara, Y.; Yamashita, K.; Kobayashi, H.; Kikuchi, H.; Harashima, H. MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion Biochim. Biophys. Acta 2008, 1778, 423-432
28. Yasuzaki, Y.; Yamada, Y.; Harashima, H. Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes Biochem. Biophys. Res. Commun. 2010, 397, 181-186
29. Yamada, Y.; Furukawa, R.; Yasuzaki, Y.; Harashima, H. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery Mol. Ther. 2011, 19, 1449-1456
30. Yamada, Y.; Harashima, H. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter. Biomaterials 2012, in press.
31. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 1986, 46, 6387-6392
32. Klibanov, A. L.; Maruyama, K.; Torchilin, V. P.; Huang, L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 1990, 268, 235-237
33. Mishra, S.; Webster, P.; Davis, M. E. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles Eur. J. Cell Biol. 2004, 83, 97-111
34. Hatakeyama, H.; Akita, H.; Kogure, K.; Oishi, M.; Nagasaki, Y.; Kihira, Y.; Ueno, M.; Kobayashi, H.; Kikuchi, H.; Harashima, H. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid Gene Ther. 2007, 14, 68-77
35. Hatakeyama, H.; Akita, H.; Ito, E.; Hayashi, Y.; Oishi, M.; Nagasaki, Y.; Danev, R.; Nagayama, K.; Kaji, N.; Kikuchi, H.; Baba, Y.; Harashima, H. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid Biomaterials 2011, 32, 4306-4316
36. Hafez, I. M.; Cullis, P. R. Roles of lipid polymorphism in intracellular delivery Adv. Drug Delivery Rev. 2001, 47, 139-148
37. Li, W.; Nicol, F.; Szoka, F. C., Jr. GALA: A designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery Adv. Drug Delivery Rev. 2004, 56, 967-985
38. Hatakeyama, H.; Ito, E.; Akita, H.; Oishi, M.; Nagasaki, Y.; Futaki, S.; Harashima, H. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo J. Controlled Release 2009, 139, 127-132
39. Sakurai, Y.; Hatakeyama, H.; Akita, H.; Oishi, M.; Nagasaki, Y.; Futaki, S.; Harashima, H. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system Biol. Pharm. Bull. 2009, 32, 928-932
40. Sakurai, Y.; Hatakeyama, H.; Sato, Y.; Akita, H.; Takayama, K.; Kobayashi, S.; Futaki, S.; Harashima, H. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA Biomaterials 2011, 32, 5733-5742